These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

455 related articles for article (PubMed ID: 8961136)

  • 1. Controlled delivery of antigens and adjuvants in vaccine development.
    Zhao Z; Leong KW
    J Pharm Sci; 1996 Dec; 85(12):1261-70. PubMed ID: 8961136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Need for new vaccine formulations and potential of particulate antigen and DNA delivery systems.
    Friede M; Aguado MT
    Adv Drug Deliv Rev; 2005 Jan; 57(3):325-31. PubMed ID: 15560944
    [No Abstract]   [Full Text] [Related]  

  • 3. Microparticles as vaccine adjuvants and delivery systems.
    O'Hagan DT; Singh M
    Expert Rev Vaccines; 2003 Apr; 2(2):269-83. PubMed ID: 12899577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fully mobilizing host defense: building better vaccines.
    Raychaudhuri S; Rock KL
    Nat Biotechnol; 1998 Nov; 16(11):1025-31. PubMed ID: 9831030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mucosal delivery of vaccine antigens and its advantages in pediatrics.
    De Magistris MT
    Adv Drug Deliv Rev; 2006 Apr; 58(1):52-67. PubMed ID: 16516335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delivery systems for molecular vaccination.
    Sheikh NA; al-Shamisi M; Morrow WJ
    Curr Opin Mol Ther; 2000 Feb; 2(1):37-54. PubMed ID: 11249651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beyond antigens and adjuvants: formulating future vaccines.
    Moyer TJ; Zmolek AC; Irvine DJ
    J Clin Invest; 2016 Mar; 126(3):799-808. PubMed ID: 26928033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccine adjuvants: smart components to boost the immune system.
    Bastola R; Noh G; Keum T; Bashyal S; Seo JE; Choi J; Oh Y; Cho Y; Lee S
    Arch Pharm Res; 2017 Nov; 40(11):1238-1248. PubMed ID: 29027637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccine adjuvant systems: enhancing the efficacy of sub-unit protein antigens.
    Perrie Y; Mohammed AR; Kirby DJ; McNeil SE; Bramwell VW
    Int J Pharm; 2008 Dec; 364(2):272-80. PubMed ID: 18555624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunity in response to particulate antigen-delivery systems.
    Storni T; Kündig TM; Senti G; Johansen P
    Adv Drug Deliv Rev; 2005 Jan; 57(3):333-55. PubMed ID: 15560945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjuvants and delivery systems based on polymeric nanoparticles for mucosal vaccines.
    Jin Z; Gao S; Cui X; Sun D; Zhao K
    Int J Pharm; 2019 Dec; 572():118731. PubMed ID: 31669213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liposomal vaccine delivery systems.
    Henriksen-Lacey M; Korsholm KS; Andersen P; Perrie Y; Christensen D
    Expert Opin Drug Deliv; 2011 Apr; 8(4):505-19. PubMed ID: 21413904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An overview of adjuvant formulations and delivery systems.
    García A; De Sanctis JB
    APMIS; 2014 Apr; 122(4):257-67. PubMed ID: 23919674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Adjuvants as factors improving efficiency of vaccination].
    Chodaczek G
    Postepy Hig Med Dosw (Online); 2004 Mar; 58():47-59. PubMed ID: 15069382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA vaccines--challenges in delivery.
    Pachuk CJ; McCallus DE; Weiner DB; Satishchandran C
    Curr Opin Mol Ther; 2000 Apr; 2(2):188-98. PubMed ID: 11249641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent advances in vaccine delivery.
    Cordeiro AS; Alonso MJ
    Pharm Pat Anal; 2016; 5(1):49-73. PubMed ID: 26667309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mucosal adjuvants and delivery systems for protein-, DNA- and RNA-based vaccines.
    Vajdy M; Srivastava I; Polo J; Donnelly J; O'Hagan D; Singh M
    Immunol Cell Biol; 2004 Dec; 82(6):617-27. PubMed ID: 15550120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioadhesive delivery systems for mucosal vaccine delivery.
    Baudner BC; O'Hagan DT
    J Drug Target; 2010 Dec; 18(10):752-70. PubMed ID: 21039314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biomaterials as vaccine adjuvants.
    Jones KS
    Biotechnol Prog; 2008; 24(4):807-14. PubMed ID: 19194892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipid-Based Nanoparticles for Delivery of Vaccine Adjuvants and Antigens: Toward Multicomponent Vaccines.
    Chatzikleanthous D; O'Hagan DT; Adamo R
    Mol Pharm; 2021 Aug; 18(8):2867-2888. PubMed ID: 34264684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.